This all looks very good and they are delivering. Oppies being exercised before trial finalised is fine. I will exercise my 2M+ as heavily derisked with a second drug candidate, we already have a win on the 2a. AND preclinical showed it stops replication so "in theory" this should mean whilst there already has been 7 days or more with the virus multiplying in the body, it should be halted from further multipication at the point that the drug enters the blood stream.
Interestingly note that they changed their IR firm in the announcement so I suspect a new group of potential investors may be introduced to ILA in the coming months.
Good luck to holders. Not long now for several game changing announcements.
Do your own research. My thoughts only, not investment advice.
ILA Price at posting:
13.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)